Multivalent Tri-Functional T-cell Engagers by Chemically Induced Protein Self-Assembly
Dahlberg, D.; McKnight, B.; Kulkarni, A.; Rozumalski, L.; Rodriguez, F.; Wang, Y.; Wagner, C. R.
Show abstract
T-cell engagers (TCEs) show promise in cancer immunotherapy but face challenges in solid tumors due to heterogeneity, antigen escape, and limited T-cell infiltration. To address this, we developed a modular platform using chemically self-assembled nanorings (CSANs). We engineered a bifunctional fusion protein, E1-DHFR2-CD3, with an EGFR-binding fibronectin (E1) and an anti-CD3 scFv on a DHFR2 scaffold. With bis-methotrexate, the monomers formed multivalent cis-CSANs. Both monomers and CSANs bound EGFR+ tumor cells and T-cells, were internalized, and induced dose-dependent, EGFR- and T-cell-dependent cytotoxicity in co-culture assays. The system was reproducible across T-cell donors. To expand targeting, E1-DHFR2-CD3 co-assembled with other DHFR2 monomers targeting GFP or EpCAM, forming trispecific CSANs capable of binding multiple antigens and mediating cytotoxicity. This platform enables the discovery of potent multispecific TCEs to address antigen escape and solid tumor heterogeneity. Future work will focus on optimizing antigen combinations to enhance efficacy across breast cancer subtypes.
Matching journals
The top 12 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- STING-Activating Polymer-Drug Conjugates for Cancer Immunotherapy 95%
- Click chemistry selectively activates an auristatin protodrug with either intratumoral or systemic tumor-targeting agents 94%
- Bioreversible anionic cloaking enables intracellular protein delivery with ionizable lipid nanoparticles 94%
Similar papers in this journal
- Dextran-based T-cell expansion nanoparticles for manufacturing CAR T cells with augmented efficacy 95%
- Antibody-drug conjugates with dual payloads for combating breast tumor heterogeneity and drug resistance 95%
- Enhancing Intracellular Accumulation and Target Engagement of PROTACs with Reversible Covalent Chemistry 94%
Similar papers in this journal
Similar papers in this journal
- Granzyme-targeting quenched activity-based probes for assessing tumor response to immunotherapy 94%
- Overcoming Immune Checkpoint Inhibitor Resistance via Potent and Selective Dual αvβ6/8 Inhibitors Based on Engineered Lasso Peptides 93%
- Identification of Covalent Cyclic Peptide Inhibitors Targeting Protein-Protein Interactions Using Phage Display 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.